| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |